IOF Blog

Rotator Cuff Tear Case Study

Introducing IOF’s Case Study Feature  The Interventional Orthopedics Foundation is committed to serving as a resource for physicians pioneering the medical subspecialty of Interventional Orthopedics. In order to best help our members expand their knowledge about...

FDA Response Regarding Chara Biologics Products

We take our role serving as stewards for our members and the Interventional Orthopedics medical sub-specialty seriously. Recently, our industry has faced several threats including the ban on stem cell therapies in Canada. We have also seen the publication of several...

IOF Expands Course Offerings to Florida and Washington

After hearing requests from Interventional Orthopedics Foundation (IOF) members all across the country, we are excited to announce IOF’s programming is expanding to bring courses to Tampa, Florida and Seattle, Washington. As the regenerative medicine field continues...

IOF 2019 Conference Videos Available for Purchase

IOF 2019 Conference Videos Available for Purchase The Interventional Orthopedics Foundation’s 2019 annual conference, #IOF2019: Controversies in Orthobiologics, brought together national and global experts to discuss the latest original research and controversial...

Dr. Ariana DeMers Joins the IOF Board

We are excited to announce the addition of Ariana DeMers, D.O. to the Interventional Orthopedics Foundation Board. “We are thrilled to add Dr. DeMers to our board,” said IOF Chairman Gerard Malanga, M.D. “Her extensive interventional orthopedics experience coupled...

FDA Warning

The U.S. Food & Drug Administration (FDA) has issued a warning letter to Cord for Life, an Altamonte Springs, Florida company that has sold umbilical-cord-blood products to stem cell companies. The FDA also issued 20 letters to companies instructing them to stop...

Birth Tissue Products Consensus and IOF Webinar Recording

The aggressive marketing of birth tissues has been one of the most controversial issues in orthobiologics in recent years. On February 18, 2019, a consensus statement provided by physicians, academics and regulatory experts was published concerning the aggressive...

Share This